Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

WASHINGTON (NEXSTAR) — Americans face a hefty price tag for diabetes and weight-loss drugs. “The people of the United States ...

According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or ...

Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study. A class of drugs for diabetes may be associated with a lower risk ...

A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a study ...

High demand for weight-loss and diabetes drugs like Ozempic and Wegovy has led to a shortage in manufacturing. In the ...

SGLT2 inhibitors are drugs that lower blood sugar levels by causing the kidneys to remove sugar from the body through urine. Lee and colleagues studied people with type 2 diabetes who started on ...